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Ether phospholipids are essential constituents
of eukaryoticcellmembranes.Rhizomelic chon-
drodysplasia punctata type 3 is a severe perox-
isomal disorder caused by inborn deficiency
of alkyldihydroxyacetonephosphate synthase
(ADPS). The enzyme carries out the most char-
acteristic step in ether phospholipid biosynthe-
sis: formation of the ether bond. The crystal
structure of ADPS from Dictyostelium discoi-
deum shows a fatty-alcohol molecule bound
in a narrow hydrophobic tunnel, specific for ali-
phatic chains of 16 carbons. Access to the tun-
nel is controlled by a flexible loop and a gating
helix at the protein-membrane interface. Struc-
tural and mutagenesis investigations identify
a cluster of hydrophilic catalytic residues, in-
cluding an essential tyrosine, possibly involved
in substrateproton abstraction, and the arginine
that is mutated in ADPS-deficient patients. We
propose that ether bond formation might be
orchestrated through a covalent imine interme-
diate with the flavin, accounting for the nonca-
nonical employment of a flavin cofactor in a
nonredox reaction.
INTRODUCTION
Ether phospholipids are major constituents of eukaryotic
cell membranes and play essential functions in signal
transduction processes, neuroplasticity, tumor growth,
and regulation of membrane fluidity and trafficking (Her-
metter et al., 1989; Thai et al., 2001; Rosenberger et al.,
2002; Rodemer et al., 2003; Gorgas et al., 2006; Wanders
and Waterham, 2006b; Chiang et al., 2006). They are a
special class of phospholipids characterized by an alkyl
or alkenyl substituent at the sn-1 position of the glycerol
backbone (Figure 1A). Phospholipids with an a,b-unsatu-
rated ether bond are called plasmalogens (Brites et al.,
2004) and include the platelet-activating factor, a potentStructure 15activator of platelet aggregation (Prescott et al., 2000).
The importance of ether phospholipids is underlined by
serious pathologies that are caused by deficiencies in
their biosynthesis. Rhizomelic chondrodysplasia punctata
(RCDP) types 2 and 3 are congenital peroxisomal disor-
ders that are biochemically defined by the inability of pa-
tients to synthesize ether phospholipids (Wanders et al.,
1994;Wanders andWaterham, 2006a). RCDP is a very se-
vere pathology that manifests with limb shortening, cata-
racts, hypotonia, and profound growth and developmen-
tal delay, ultimately leading to death in the first 5–10
years of life (White et al., 2003). As for most peroxisomal
disorders, there is currently no treatment for the disease.
RCDP type 3 is caused by inborn deficiency of alkyldihy-
droxyacetonephosphate synthase (ADPS) (Wanders et al.,
1994; de Vet et al., 1998a), a peroxisomal enzyme that car-
ries out the most characteristic step in the ether phospho-
lipid biogenesis: formation of the ether bond (Hajra, 1970;
Wykle et al., 1972; de Vet and van den Bosch, 2000) (Fig-
ure 1A). ADPS catalyzes the synthesis of alkyldihydroxy-
acetonephosphate (alkyl-DHAP) through the exchange
of the acyl moiety of acyl-DHAP with a fatty alcohol (Fig-
ure 1A). The enzyme uses FAD as an essential cofactor
for catalysis (deVet et al., 2000). This is an intriguing feature
in that the reaction does not involve any net redox modifi-
cation of the substrate. From an enzymological perspec-
tive, the flavin-dependent reaction catalyzed by ADPS
poses many puzzling questions, and its mechanism
remains an unsolved problem.
ADPS forms a complex with DHAP-acyltransferase, the
enzyme that produces the substrate for the ADPS reaction
(de Vet et al., 1999). The complex is thought to be associ-
ated with the luminal face of the peroxisomal membrane.
The most extensively characterized ADPS is the enzyme
from guinea pig, which has been expressed in Escherichia
coli and subjected to fast-kinetics investigations (de Vet
et al., 1997a, 2000; de Vet and van den Bosch, 1999).
ADPS has been identified and partly characterized also
in other organisms, including Homo sapiens (de Vet et al.,
1997b), Caenorhabditis elegans (de Vet et al., 1998b), Try-
panosoma brucei (Zomer et al., 1999), and Dictyostelium
discoideum (de Vet and van den Bosch, 1998). The mam-
malian enzymes carry a perixosomal targeting signal type
2 in N-terminal cleavable presequences, whereas the, 683–692, June 2007 ª2007 Elsevier Ltd All rights reserved 683
Structure
Alkyldihydroxyacetonephosphate SynthaseFigure 1. Biochemical and Functional Properties of ADPS
(A) General chemical formula of an ether phospholipid and scheme of the reaction catalyzed by ADPS.
(B) Alignment of the sequence of D. discoideum (DICDI), guinea pig (CAVPO), and human ADPS. Conserved residues are boxed in red, whereas
homologous amino acids are written in red. Secondary-structure elements refer to the D. discoideum three-dimensional structure.
(C) Time courses of hexadecanyl-DHAP synthesis catalyzed by recombinant guinea pig ADPS (square) (prepared as described by de Vet and van den
Bosch, 1999), wild-typeD. discoideumADPS (open circle),D. discoideumArg352Hismutant (gray circle), andD. discoideum Tyr508Phemutant (filled
circle), which exemplifies the case of an inactive mutant (Table 2). Experimental conditions of the assay are described in Experimental Procedures.
The molar ratio of the product formed at increasing reaction times and the enzyme present in each assay mixture is reported.C. elegans and D. discoideum homologs have a targeting
signal type 1 at the C terminus.
Here we report the three-dimensional structure and bio-
chemical and mutagenesis investigations on ADPS from
D. discoideum. Our studies suggest a mechanistic frame-
work to the unusual reaction catalyzed by ADPS and to
themutation underlying the enzymatic deficiency affecting
RCDP type 3 patients.
RESULTS AND DISCUSSION
Structure Determination
In aneffort to investigate the structural biologyofADPS,we
initially expressed and purified the recombinant enzymes
from guinea pig and, later, from Drosophila melanogaster
and Archaeoglobus fulgidus. However, in all three cases,
the proteins resisted crystallization, exhibiting a strong
tendency to aggregate and poor stability. For this reason,
we undertook the investigation of ADPS from D. discoi-
deum, which turned out to be a stable protein suitable for
biochemical and structural studies. The enzyme consists684 Structure 15, 683–692, June 2007 ª2007 Elsevier Ltd All rigof 611 amino acids and a tightly noncovalently bound
FAD. It shares 33% sequence identity with guinea pig
and human homologs (Figure 1B) and enzymatic activity
comparable to that of the guinea pig protein using palmi-
toyl-DHAP and hexadecanol as substrates (Figure 1C).
Efforts to crystallize full-length ADPS from D. discoi-
deum failed. Based on limited proteolysis and second-
ary-structure prediction, we designed a truncated mutant
spanning amino acids 9–587 which crystallized in two
forms, belonging to space groups P1 and P212121 and
diffracting to 2.0 A˚ resolution. The structure was solved
by single-wavelength anomalous diffraction (Table 1). In
both crystal forms there are four monomers in the asym-
metric unit, corresponding to two dimers (Figure 2A).
Gel-filtration experiments support the observation that
ADPS is dimeric also in solution. The structures of the
crystallographically independent subunits do not signifi-
cantly differ, as indicated by root-mean-square deviations
ranging from 0.45 to 0.80 A˚ for equivalent Ca atoms. The
largest variations are observed on flexible loops, espe-
cially loop 366–374 between a12 and a13 (Figure 1B).hts reserved
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Alkyldihydroxyacetonephosphate SynthaseTable 1. Data Collection and Refinement Statistics
Native 1 Se-Met Native 2
Data Collection
Space group P1 P1 P212121
a, b, c (A˚) 77.8, 98.0, 107.0 78.3, 98.5, 107.0 103.5, 108.9, 216.5
a, b, g () 114, 93, 103 114, 93, 103 90, 90, 90
Resolution (A˚)a 48.4–2.0 (2.1–2.0) 48.3–2.4 (2.5–2.4) 29.9–1.95 (2.06–1.95)
Rmerge (%)
a,b 8.3 (40.3) 6.0 (30.3) 11.0 (42.1)
Number of unique reflections 176,351 106,218 177,635
I/s(I)a 12.4 (3.4) 24.8 (5.0) 12.5 (3.2)
Completeness (%)a 95.3 (89.0) 96.6 (85.1) 99.8 (100)
Redundancya 4.6 (3.9) 7.9 (7.7) 5.1 (5.2)
Refinement
R factor (Rfree)
c 22.6 (26.4) 19.3 (24.4)
Atoms (protein/FAD/alcohol) 16,390/212/51 17,363/212/68
Waters 1,302 1,550
Number of residues (A/B/C/D) 523/523/491/528 550/540/541/537
Rms deviationsd
Bond lengths (A˚) 0.020 0.015
Bond angles () 1.68 1.44
Ramachandrane
Most favorable (%) 90.3 90.0
Disallowed (%) 0.0 0.0
aData for the highest resolution shell are given in parentheses.
b Rmerge = ShSijI(hkl)  <I(hkl)>j/ShSiI(hkl).
c R factor = SjjFobsj  jFcalcjj/SjFobsj. Rfree is the R factor value for 5% of the reflections excluded from the refinement. Data for the
highest resolution shell are given in parentheses.
d Root-mean-square deviations from ideal values were calculated with REFMAC5 (Murshudov et al., 1997).
e Figures from PROCHECK (Laskowski et al., 1993).The P212121 crystals display a higher degree of order and,
therefore, we will refer to monomer A of this crystal form
for structure description and analysis.
Overall Structure
ADPS is a dimer of overall dimensions 112 A˚3 70 A˚3 60 A˚
(Figure 2A). According to a Protein Data Bank (Berman
et al., 2002) search by DALI (Holm and Sander, 1993), its
overall folding topology resembles that of the vanillyl-alco-
hol oxidase family of flavoenzymes (Fraaije et al., 1998).
ADPS consists of a FAD-binding domain spanning resi-
dues 94–315 and 543–587, a cap domain comprising res-
idues 316–542, and an N-terminal domain consisting of
residues 9–93 (Figure 2B). This third domain has not been
found in other members of the vanillyl-alcohol oxidase
family and consists of a b sheet (strands b1–b3) and helix
a1, which we call the ‘‘gating helix’’ because it is involved
in substrate tunnel closure (Figure 2B).
The loop connecting strand b12 to helix a10 (residues
280–292) of one subunit penetrates into the other sub-
unit’s active site, so that the two subunits are embracingStructure 15,each other (Figure 2). Four to seven amino acids of this
loop are not visible in the electron density in all monomers.
Another disordered loop is close to the C terminus be-
tween helices a17 and a18 (residues 543–562). We will
refer to it as the ‘‘HHH loop’’ (Figure 2B) because it con-
tains three well-conserved histidines that have a role in
substrate binding and/or activity (Figure 1B; Table 2).
The FAD coenzyme binds to ADPS in an extended con-
formation and orients its si face toward the substrate
(Figure 3A). It is embedded in the protein structure, estab-
lishing a number of van der Waals interactions and H
bonds mainly with residues of the FAD-binding domain.
The isoalloxazine ring is planar and partially exposed to
the solvent as a result of the disorder of the HHH loop
(Figure 3A).
Fatty-Alcohol Tunnel
Electron density maps unambiguously revealed an elon-
gated feature close to the isoalloxazine ring in all subunits
of the two crystal forms, with the exception of subunit C
of the P1 structure (ligand-free monomer). The electron683–692, June 2007 ª2007 Elsevier Ltd All rights reserved 685
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Alkyldihydroxyacetonephosphate Synthasedensity is fully consistent with a C16 fatty alcohol, although
we cannot rule out that the recombinant protein contains
a mixture of linear aliphatic molecules (Figure 3B). Mass
spectrometry experiments failed to give a clear and defi-
nite answer relative to the nature of the ligand. It could
only be suggested that crystalline ADPS binds a molecule
with a mass of 250 ± 30 Da (data not shown). As it was
not added to culture media or solutions during bacterial
growth and protein purification, it must represent an en-
dogenous compound that became bound to the enzyme
during its production in E. coli cells. The fatty alcohol binds
in a narrow tunnel with a length of 18 A˚ and a surface area
of about 300 A˚2. It extends from the flavin to the protein
surface where the so-called gating helix is located (Fig-
ure 2B). The walls of the tunnel consist of aliphatic and
aromatic side chains. The only charged group is Arg447,
whose side chain runs parallel to the fatty alcohol and es-
Figure 2. Global View of the ADPS Three-Dimensional Struc-
ture
(A) Overall structure of the ADPS dimer. The FAD (carbon, yellow; nitro-
gen, blue; oxygen, red; phosphorus, orange) and the fatty alcohol (car-
bon, green; oxygen, red) are depicted in stick representation.
(B) The ADPS monomer in the same orientation as in Figure 2A. The
FAD-binding domain is in blue, the cap domain is in red, and the N-ter-
minal domain is in green. The gating helix is in gray. The fatty alcohol is
shown as green CPK.686 Structure 15, 683–692, June 2007 ª2007 Elsevier Ltd All rigtablishes van der Waals contacts with the ligand aliphatic
tail (Figure 3C), whereas its charged group interacts with
watermolecules and the carbonyl of Lys124. The essential
role played by Arg447, a strictly conserved residue (Fig-
ure 1B), is highlighted by our mutagenesis studies. Re-
placement of Arg447 with a Leu makes the enzyme inac-
tive and unable to bind FAD strongly (Table 2).
Fatty-Alcohol Binding Modes
The conformation and binding mode of the fatty alcohol
slightly differ among the ADPS subunits. In the most
typical binding mode, the fatty alcohol fills the tunnel, as-
suming an extended conformation that spans the 17 A˚ dis-
tance between Leu63 and Tyr508, which H bonds the
hydroxyl group of the ligand (Figures 3A and 3C). Such
an ‘‘in’’ mode of binding places the ligand C1-OH group
in contact with the pyrimidine ring of the flavin (distance
4.3 A˚), and it is found in subunit B of the P1 crystals and
in subunits A, B, andCof the P212121 structure (Figure 3B).
In a second binding mode (subunits A and D of the P1
structure), the fatty alcohol adopts an L-shaped confor-
mation, with its hydroxyl pointing away from the flavin
ring toward the protein surface (‘‘bent’’ mode) (Figure 3A).
In subunit D of the P212121 structure, the fatty alcohol is in
an extended conformation similar to that of the ‘‘in’’ mode.
However, relative to this mode, the ligand is shifted away
from the flavin by about 3 A˚ (‘‘out’’ mode) (Figure 3A).
Tunnel Entrances
The tunnel is accessible from the flavin si face as a conse-
quence of HHH loop disorder (Figures 2B and 3A). The es-
sential role of the loop for activity has been demonstrated
by our mutagenesis data on the D. discoideum protein
(Table 2) and previous studies on the guinea pig enzyme
(de Vet and van den Bosch, 1999; de Vet et al., 2000).
The negatively charged phosphate moiety of the acyl-
DHAP substrate might interact with the histidine cluster
so that substrate binding might trigger closure of the
HHH loop, shielding the active site from solvent.
The access through the other tunnel entrance appears
to be controlled by the gating helix (Figure 2B). Inspection
of the B factor values of the helix residues reveals a steady
increase from the N terminus to the C terminus, the aver-
age B factor being 20–30 A˚2 higher on the C-terminal he-
lical end. This observation is consistent with the idea that
Table 2. Active Site Mutants
Mutant Activity
Arg352His Thirty-fold reduction in activity
Arg447Leu Inactive; the FAD binds poorly
to the mutant enzyme
Tyr508Phe Inactive
His544Ile Inactive
His545Ile Inactive
His546Ile Inactivehts reserved
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Alkyldihydroxyacetonephosphate SynthaseFigure 3. The Fatty-Alcohol Binding Site
(A) Molecular surface of ADPS in the region surrounding the active site. The surface of the fatty-alcohol tunnel is shown in red. The three observed
binding modes of the fatty alcohol are superposed: ‘‘in’’ mode, green; ‘‘bent’’ mode, blue; ‘‘out’’ mode, red. The FAD is colored as in Figure 2A.
(B) The experimental electron density map (B subunit of the P1 structure) for FAD and fatty alcohol is shown as red mesh at 1 s contour level.
(C) Scheme of the protein-fatty alcohol interactions (‘‘in’’ mode of binding).the C-terminal residues of the gating helix can be quite
flexible, as suggested by the fact that the helix adopts dif-
ferent conformations in the various protein chains. These
conformational differences do not appear to be directly
caused by crystal packing, because the gating-helix resi-
dues are not involved in crystal contacts. In the ligand-free
subunit, the C-terminal end of the helix is unstructured and
both Leu63 and Glu62 are disordered. As a result, the tun-
nel entrance is open (Figure 4). In the subunit with the
ligand bound in the ‘‘out’’ mode, Glu62 is visible in the
electron density although it adopts a more exposed con-
formation compared to that found in the ‘‘in’’ mode sub-Structure 15,units. This makes the tunnel partially open. The C terminus
of the gating helix becomes fully defined by the electron
density only when the fatty alcohol binds in the ‘‘in’’
mode. In this case, ordered Leu63 closes up the tunnel,
making it solvent inaccessible (Figure 3A). The different
conformations of the gating helix may correspond to dif-
ferent steps during the entrance of the fatty alcohol into
the tunnel: (1) the tunnel is open in the ligand-free enzyme;
(2) the ‘‘out’’ and ‘‘bent’’ modes might represent interme-
diate states in the binding process; and (3) the ‘‘in’’ confor-
mation is the final catalytically relevant position of the fatty
alcohol.683–692, June 2007 ª2007 Elsevier Ltd All rights reserved 687
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Alkyldihydroxyacetonephosphate SynthaseFigure 4. Molecular Surface of ADPS at
the Tunnel Entrance Close to the Gating
Helix
The surface was calculated using the coordi-
nates of the ligand-free subunit (monomer C
of the P1 structure) in which the C terminus of
the gating helix is unstructured and the tunnel
entrance is open. The superposed binding
modes of the fatty alcohol (‘‘in’’ mode, green;
‘‘bent’’ mode, blue; ‘‘out’’ mode, red) are
depicted to illustrate their positions relative to
the tunnel entrance.Membrane Association
Biochemical studies on guinea pig ADPS suggest that it
associates with the perixosomal membrane (de Vet and
van den Bosch, 2000). However, ADPS does not contain
a well-defined membrane-binding domain, as, for exam-
ple, D-lactate dehydrogenase, a peripheral membrane
protein of the vanillyl-alcohol oxidase family (Dym et al.,
2000). Instead, the ADPS surface exhibits an electroposi-
tive patch generated by the clustering of several positively
charged residues including Lys60, Lys61, and Lys71,
which belong to the gating helix (Figure 5). These posi-
tively charged residues are suited to interact with the neg-
ative heads of membrane phospholipids. Sequence align-
ments show that only three of these positive residues are
conserved in the guinea pig and human enzymes. How-
ever, on helices a13 and a14, which mostly contribute to
the electropositive surface, the total number of basic res-
idues is maintained (Figure 1B). Thus, the surface poten-
tial, defined as the net sum of positive residues, is essen-
tially conserved.688 Structure 15, 683–692, June 2007 ª2007 Elsevier Ltd All rigStructure and Mutagenesis of the Active Site:
Molecular Basis of a Disease
The catalytic center and flavin-binding region are charac-
terized by a cluster of charged and hydrophilic residues,
which are strictly conserved in sequence: Asp237, Arg352,
Arg447, Glu461, and Tyr508 (Figures 1B and 6). Asp237 is
at the heart of this cluster, forming a water-mediated H
bond with the flavin N5 atom. A homologous Asp is found
also in certain members of the vanillyl-alcohol oxidase
family, where it has been shown to be crucial for activity
and modulation of the flavin redox potential (van den Heu-
vel et al., 2000). Asp237 forms a bidentate salt bridge with
Arg352 and also interactswith Arg440. Arg352 is a key res-
idue, as replacement of the homologous Arg419 of the
human enzyme by His is the mutation underlying RCDP
type 3 disease (de Vet et al., 1998a). The essential role of
this amino acid is demonstrated by our mutagenesis ex-
periments on the D. discoideum protein, which show that
the Arg352His mutation drastically reduces activity (Table
2; Figure 1C). Arg352 (Arg419) was postulated to bind theFigure 5. Electrostatic Potentials of the
ADPS Dimer Surface
Red, blue, andwhite show potentials at8, +8,
and 0 kBT e
1, respectively. The basic amino
acids forming the membrane-binding region
are labeled.hts reserved
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Alkyldihydroxyacetonephosphate Synthasephosphate moiety of the substrate (de Vet et al., 1998a).
However, the crystal structure now indicates that Arg352
is on the opposite side of the flavin relative to the substrate.
The residue is positioned on the b16 strand rather than in
a mobile loop, making a large conformational change un-
likely. Arg352 appears to have a role in maintaining the
structural integrity of the catalytic center through its inter-
action with Asp237 and, possibly, in providing the proper
electrostatic environment for the modulation of flavin
reactivity.
Another interesting residue is Tyr508, which comes
deep into the active site, being engaged in a hydrogen
bond with the hydroxyl of the fatty alcohol when bound
in the ‘‘in’’ mode. Mutation of Tyr508 to Phe causes en-
zyme inactivation, emphasizing its essential role (Table
2; Figure 1C). A possible function of this residue might
be in acid/base catalysis, as discussed in the next section.
On the Reaction Mechanism
The ADPS reaction (Figure 1A) follows a ping-pong mech-
anism—that is, the fatty-acid product is released before
binding of the fatty alcohol (Brown and Snyder, 1982).
The three-dimensional structure highlights a single hydro-
phobic tunnel that can host an aliphatic chain of 16 car-
bons, in agreement with the preference of ADPS for palmi-
toyl-DHAP and hexadecanol (de Vet and van den Bosch,
2000). By combining biochemical and structural data, the
following scheme for the catalytic cycle can be proposed
(Figure 7A). The reaction starts with the binding of acyl-
DHAP; its acyl group extends into the tunnel, whereas
its DHAPmoiety is located in the wide cavity in front of the
flavin ring (step 1 in Figure 7A). Next, the fatty-acid product
Figure 6. Active Site of ADPS
Nitrogens and oxygens are blue and red, respectively. Carbons of the
fatty-alcohol, FAD, and protein residues are green, yellow, and gray,
respectively. Hydrogen bonds are shown as dashed lines.Structure 15, 6is generated and released through the movement of the
gating helix (step 2 in Figure 7A). Only at this stage can
the fatty alcohol enter the tunnel with its OH group ori-
ented toward the flavin, and synthesis of the alkyl-DHAP
product finally takes place (steps 3 and 4 in Figure 7A).
The function of the gating helix in product release and sub-
strate binding is of particular interest. The helix is part of
the positively charged patch on the protein surface that
likely interacts with the membrane (Figure 5). This feature
implies that the release of the fatty-acid product and the
entrance of the fatty-alcohol substrate occur at the inter-
face between protein and phospholipid bilayer, as ob-
served in other membrane-associated enzymes that act
on lipophilic molecules (see http://blanco.biomol.uci.edu/
membrane_proteins_xtal.html). Another key element in
substrate binding is the HHH loop. Mutations targeting
the loop’s His residues abolish activity (Table 2). The loop,
which is disordered in the crystal structure, possibly be-
comes ordered upon acyl-DHAP binding. ADPS is known
to form a complex with DHAP-acyltransferase, which syn-
thesizes the substrate of ADPS and is active only in the
presence of ADPS (de Vet et al., 1999). An intriguing
idea is that the highly conserved HHH loop might be in-
volved in either protein-protein interactions and/or chan-
neling of acyl-DHAP across the two enzyme active sites.
At the heart of the ADPS catalytic cycle is the ability to
trap the DHAP moiety to allow the substitution of the
acyl chain with the alkyl group (Figure 7A). Stopped-flow
experiments on the guinea pig enzyme have demon-
strated that during the reaction there is formation of an
oxygen-insensitive reduced form of FAD, which is possi-
bly a covalent adduct (de Vet et al., 2000). Moreover,
biochemical studies have shown that the pro-R proton
(or hydrogen) of DHAP C1 (Figures 1A and 7B) is ex-
changed with solvent (Friedberg et al., 1980; Brown and
Snyder, 1983). A potential base is Tyr508, which is within
H-bond distance from the fatty-alcohol hydroxyl group
(Figures 3C and 6). Mutagenesis studies show that the
Tyr508Phe mutation inactivates the enzyme, highlighting
the key role of the Tyr508 side chain (Table 2). Proton ab-
straction would generate a carbanion intermediate whose
charge can be delocalized on the DHAP carbonyl and
phosphate groups (Figure 7B). Furthermore, the essential
His residues of the HHH loop might compensate for the
developing negative charge. The three-dimensional struc-
ture shows that the hydroxyl group of the fatty alcohol
bound to ADPS in the ‘‘in’’ mode is oriented toward the
flavin, in contact with its central and pyrimidine rings (Fig-
ure 3). Assuming a similar binding mode for the acyl group
of acyl-DHAP, the DHAP moiety is expected to bind with
its C1 in front of the flavin N5 (Figure 7B). Therefore, after
proton abstraction, the deprotonated nucleophilic C1
could attack the flavin N5 atom and generate a covalent
adduct (Figure 7B). The fatty acid could then be released,
with formation of a cationic flavin-imine intermediate. This
mechanistic scheme predicts that the fatty-acid product
retains both oxygens of the acyl-DHAP ester bond, in
agreement with isotope labeling data (Friedberg et al.,
1983; Brown et al., 1985). In the second part of the83–692, June 2007 ª2007 Elsevier Ltd All rights reserved 689
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Alkyldihydroxyacetonephosphate SynthaseFigure 7. Structural Framework for ADPS Catalysis
(A) A structural framework for the reaction cycle of ADPS. Step 1, ADPS binds the acyl-DHAP substrate; the HHH loop becomes ordered and the
gating helix closes the tunnel. Step 2, the fatty-acid product (R1COOH) is generated and released, whereas the DHAP moiety remains trapped in
the active site. Step 3, the fatty alcohol (R2OH) binds in the tunnel. Step 4, the alkyl-DHAP product is formed and released.
(B) Working hypothesis for the reaction mechanism of ADPS.ping-pong reaction (Figure 7A), the fatty alcohol enters the
tunnel and its hydroxyl group reacts with the flavin-imine
intermediate, yielding the alkyl-DHAP product whose
ether bond oxygen derives from the alcohol, as indicated
by biochemical evidence (Figure 7B) (Friedberg et al.,690 Structure 15, 683–692, June 2007 ª2007 Elsevier Ltd All1983; Brown et al., 1985). Thus, the integration of bio-
chemical and structural data indicates that trapping of
DHAPmight be orchestrated through formation of a cova-
lent imine intermediate with the flavin (Valley et al., 2005).
We emphasize that the available biochemical andrights reserved
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Alkyldihydroxyacetonephosphate Synthasestructural data do not completely rule out other mechanis-
tic proposals. Our mechanistic model represents a work-
ing hypothesis that will provide the basis for future studies
on the remarkable reaction catalyzed by ADPS.
EXPERIMENTAL PROCEDURES
Protein Overexpression, Purification, and Mutagenesis
Overexpression and purification of ADPS from D. discoideum will be
described elsewhere. Briefly, the full-length and 9–587 enzymes were
overexpressed in E. coli cells (BL21 strain) as His-tag fusion proteins.
The proteins were purified by affinity chromatography on an Ni-NTA
column followed by cation-exchange chromatography and gel filtra-
tion. The His tagwas removed by proteolysis. The Se-Met-labeled pro-
tein was purified following the same protocol, except that 5 mM DTT
was added to all buffers.
Single mutations were inserted in the full-length construct by Quik-
Change mutagenesis kit (Stratagene) according to the manufacturer’s
instructions and confirmed by DNA sequencing. Mutant proteins were
purified as was the wild-type enzyme.
Activity Assays
Palmitoyl-DHAP was synthesized as described by Hajra and Agranoff
(1967). Enzymatic activity was assayed using radioactive [1-14C]hexa-
decanol (Zomer et al., 1993). The following assay conditions were
used: 50 mM Tris-HCl (pH 8.2), 50 mM NaF, 0.1% (w/v) Triton X-100,
100 mM acyl-DHAP, and 96 mM [1-14C]hexadecanol (Sigma; specific
radioactivity adjusted to 13,000 dpm/nmol) in a total volume of
100 ml at 37C. Aliquots (10 ml) were withdrawn at different times and
spotted on DEAE cellulose disks. After an extensive wash with ethanol,
the disks were transferred to scintillation vials and counted by means
of a Tri-Carb 2100TR (Packard) scintillation counter to measure the
amount of radioactive hexadecanyl-DHAP product formed.
Crystallization and Data Collection
Protein solutions used for crystallization contained 14–20mg/ml 9–587
ADPS, 100 mM NaCl, 50 mM NaH2PO4, 20 mM MES (pH 6.0), and
1mMDTT. The protein was crystallized by the hanging-drop vapor-dif-
fusion method using reservoir solutions consisting of 10%–12% (w/v)
PEG4000, 200 mM Li2SO4, and 100 mM Tris-HCl (pH 8.5) at 20
C. The
first crystals appeared after about 2 months. Microseeding reduced
the rate of crystallization to a few days. The crystals belong to space
group P1 (Table 1). When the cell pellets were suspended in a buffer
containing 0.25%–0.5% (w/v) Triton X-100, besides the usual P1 crys-
tals another crystal form was obtained, which belongs to space group
P212121 (Table 1). In both crystal forms there are two dimers in the
asymmetric unit.
For data collection, crystals were flash-frozen in liquid nitrogen after
exposure to a cryoprotectant solution consisting of the crystallization
mother liquor containing 30%–35% (v/v) PEG400. Data were collected
at the European Synchrotron Radiation Facility (Grenoble, France).
MOSFLM (Leslie, 1999) and CCP4 (CCP4, 1994) programs were used
for data processing.
Structure Solution and Refinement
The P1 structure was solved by single-wavelength anomalous diffrac-
tion. The Se substructure was solved by SHELXD (Schneider and Shel-
drick, 2002). Initial phases were calculated by SHELXE and further
improved by four-fold density averaging using dm (Cowtan, 1994).
The resulting electron density maps were subjected to ARP/wARP
(Perrakis et al., 1999) automated model building alternated by RE-
FMAC5 (Murshudov et al., 1997) refinement, which traced about 70%
of the model. Manual model building was performed using Coot (Ems-
ley and Cowtan, 2004), whereas REFMAC5 and ARP were employed
for crystallographic refinement and location of the solvent molecules.
Noncrystallographic symmetry restraints were applied throughout
the refinement, except to those residues that clearly adopted differentStructure 15,conformations in the crystallographically independent subunits. The
P212121 structure was solved by molecular replacement using the P1
structure as a search model. The refinement statistics are reported in
Table 1. The three-dimensional models were analyzed by programs
of the Uppsala Software Factory (Kleywegt and Jones, 1994) and
CCP4 suite (CCP4, 1994). Figures were prepared with PyMOL (http://
www.pymol.org) and ESPript (Gouet et al., 1999).
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